⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1587915 | 0.77 | — | — | |
| SCHEMBL2787313 | 0.72 | — | — | |
| SCHEMBL10952898 | 0.71 | — | — | |
| SCHEMBL827234 | 0.70 | — | — | |
| SCHEMBL17185621 | 0.70 | — | — | |
| SCHEMBL27977648 | 0.70 | — | — | |
| SCHEMBL438580 | 0.70 | — | — | |
| SCHEMBL5175382 | 0.70 | — | — | |
| SCHEMBL3995492 | 0.70 | — | — | |
| SCHEMBL29373070 | 0.70 | IMPDH2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112028892-B | Application of 4-amino-pyrrolotriazine derivative in preparation of anti-pulmonary fibrosis preparation | 天津全和诚科技有限责任公司 | 2022-12-16 | — | — | CN | claimed |
| CN-112028892-B | Application of 4-amino-pyrrolotriazine derivative in preparation of anti-pulmonary fibrosis preparation | 天津全和诚科技有限责任公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-110494480-A | Rubber composition, the manufacturing method of rubber composition and tire | BRIDGESTONE CORP | 2019-11-22 | — | — | CN | disclosed |
| CN-109415457-A | The method for preparing functionalized polymeric | 株式会社普利司通 | 2019-03-01 | — | — | CN | disclosed |
| US-20160362392-A1 | GLUCAGON RECEPTOR MODULATORS | PFIZER INC. (US) | 2016-12-15 | — | — | US | disclosed |
| US-9452999-B2 | Glucagon receptor modulators | PFIZER INC. (US) | 2016-09-27 | — | — | US | disclosed |
| EP-2673260-B1 | GLUCAGON RECEPTOR MODULATOR | PFIZER (US) | 2016-08-17 | — | — | EP | disclosed |
| US-20150266859-A1 | GLUCAGON RECEPTOR MODULATORS | PFIZER INC. (US) | 2015-09-24 | — | — | US | disclosed |
| US-9073871-B2 | Glucagon receptor modulators | PFIZER INC. (US) | 2015-07-07 | — | — | US | disclosed |
| US-20140371467-A1 | GLUCAGON RECEPTOR MODULATORS | PFIZER INC. (US) | 2014-12-18 | — | — | US | disclosed |
| WO-2005097743-A1 | SYNTHESIS OF PYRROLE-2-CARBONITRILES | WYETH (US) | 2005-10-20 | — | — | WO | disclosed |
| EP-1051431-A1 | THROMBIN INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-15 | — | — | EP | disclosed |
| EP-0956294-A1 | THROMBIN INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 1999-11-17 | — | — | EP | disclosed |
| WO-1999037668-A1 | THROMBIN INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-29 | — | — | WO | disclosed |
| WO-1998006741-A1 | THROMBIN INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 1998-02-19 | — | — | WO | disclosed |
| US-4511575-A | Antidiabetic pyrrolecarboxylic acids | PFIZER INC. (US) | 1985-04-16 | — | — | US | disclosed |
| US-4511576-A | Antidiabetic pyrrolecarboxylic acids | PFIZER INC. (US) | 1985-04-16 | — | — | US | disclosed |
| US-4351843-A | LOWERING BLOOD GLUCOSE | PFIZER INC. (US) | 1982-09-28 | — | — | US | disclosed |
| US-4282242-A | HYPOGLYCEMIC AGENTS | PFIZER INC. (US) | 1981-08-04 | — | — | US | disclosed |
| US-4006160-A | Process for the synthesis of N-hydroxypyrroles, N-hydroxyimidazoles, and derivatives thereof | UNIVERSITY OF ALABAMA (US) | 1977-02-01 | — | — | US | disclosed |